Literature DB >> 22975844

Downregulation of MSP58 suppresses cell proliferation in neuroblastoma cell lines.

Lin Wu1, Zhi-guo Zhang, Huai-zhou Qin, Jian Zhang, Guo-dong Gao, Wei Lin, Jiang Wang, Jing Zhang.   

Abstract

MSP58, a novel oncogene, shows transforming activity in mouse embryonic fibroblasts. However, the oncogenic role of MSP58 in tumor cells has not been fully characterized. To extend understanding of how this protein operates in tumorigenesis, we aimed to identify the effect of MSP58 on neuroblastoma cell proliferation. Here, we found that MSP58 was highly expressed in neuroblastoma tumor samples and cell lines. We found that the majority of MSP58 protein can be detected in the nucleus as reported in other cells. Moreover, MSP58-targeted shRNA lentivirus attenuated neuroblastoma cell proliferation. Knockdown of MSP58 resulted in S-phase cell accumulation, which was accompanied by changes in cell cycle-related molecules. These results indicate that MSP58 plays an oncogenic role in the proliferation of neuroblastoma cells and could be a novel target for the treatment of neuroblastoma.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22975844     DOI: 10.1097/WNR.0b013e328359566e

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  3 in total

Review 1.  Using Xenopus to discover new genes involved in branchiootorenal spectrum disorders.

Authors:  Sally A Moody; Karen M Neilson; Kristy L Kenyon; Dominique Alfandari; Francesca Pignoni
Journal:  Comp Biochem Physiol C Toxicol Pharmacol       Date:  2015-06-24       Impact factor: 3.228

2.  MCRS1 Expression Regulates Tumor Activity and Affects Survival Probability of Patients with Gastric Cancer.

Authors:  Liang-Han Wang; Chih-Chun Chang; Chiao-Yin Cheng; Yao-Jen Liang; Dee Pei; Jen-Tang Sun; Yen-Lin Chen
Journal:  Diagnostics (Basel)       Date:  2022-06-20

3.  Expression of MCRS1 and MCRS2 and their correlation with serum carcinoembryonic antigen in colorectal cancer.

Authors:  Chenguang Li; Mingxiao Chen; Pingwei Zhao; Desalegn Admassu Ayana; Lei Wang; Yanfang Jiang
Journal:  Exp Ther Med       Date:  2016-06-03       Impact factor: 2.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.